These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours. Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037 [TBL] [Abstract][Full Text] [Related]
7. Determinants of surgical resection for pancreatic neuroendocrine tumors. Doi R J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163 [TBL] [Abstract][Full Text] [Related]
8. A personal experience with pancreatic and duodenal neuroendocrine tumors. Jordan PH J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736 [TBL] [Abstract][Full Text] [Related]
9. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas. Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582 [TBL] [Abstract][Full Text] [Related]
10. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients]. Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008 [TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395 [TBL] [Abstract][Full Text] [Related]
17. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience. You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW Eur J Surg Oncol; 2009 Jul; 35(7):728-33. PubMed ID: 19188040 [TBL] [Abstract][Full Text] [Related]
18. Is the new classification of neuroendocrine pancreatic tumors of clinical help? Schindl M; Kaczirek K; Kaserer K; Niederle B World J Surg; 2000 Nov; 24(11):1312-8. PubMed ID: 11038199 [TBL] [Abstract][Full Text] [Related]
19. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series. Paiella S; Marchegiani G; Miotto M; Malpaga A; Impellizzeri H; Montagnini G; Pollini T; Nessi C; Butturini G; Capelli P; Posenato I; Scarpa A; D'Onofrio M; De Robertis R; Cingarlini S; Boninsegna L; Bassi C; Salvia R; Landoni L Neuroendocrinology; 2018; 106(3):234-241. PubMed ID: 28586782 [TBL] [Abstract][Full Text] [Related]
20. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]